News

SEMA4 PRESS RELEASE | 10.17.17

Sema4 Announces Collaboration with California Cryobank to Improve and Expand Genetic Screening for Sperm Donors

“Sema4, a Mount Sinai venture providing advanced genomic testing, and California Cryobank (Cryobank), the worldwide leader in frozen donor sperm and egg banking, today announced a collaboration to bring comprehensive genetic screening to new Cryobank sperm donors via its DNA Advantage™ Program utilizing the Sema4 Expanded Carrier Screen…”
READ MORE
STAMFORD ADVOCATE | 10.11.17

Stamford Mayor Welcomes “Exciting” Biotech Firm to City

“Sema4, a genomic testing company spun off earlier this year from the Mount Sinai Health System in Manhattan, announced Wednesday its arrival in Stamford with a press conference featuring Mayor David Martin. Last month, the company opened its headquarters in 28,000 square feet in the office complex at 333 Ludlow St., where it employs about 75…”
READ MORE
THE NEW YORK TIMES | 10.03.17

Personal Genetic Testing Is Here. Do We Need It?

“So far some two dozen companies have partnered with Helix. One is Sema4, which was spun out of the Mount Sinai Health System and sells a test on the Helix platform that determines whether people are “carriers” of genetic variants linked to 67 hereditary disorders, including cystic fibrosis, sickle cell anemia and Tay-Sachs disease. Dr. Eric Topol, a cardiologist and professor of genomics at the Scripps Research Institute in California, said there was great potential value in consumer genomics tests, particularly with services like those developed by Geisinger, Invitae and Sema4 that are backed by strong data…”
READ MORE
SEMA4 PRESS RELEASE | 10.03.17

Sema4 Appoints Fertility Expert Alan Copperman, MD, as Chief Medical Officer

“Sema4 today announced the appointment of Alan B. Copperman, MD, as Chief Medical Officer. Dr. Copperman is Director of the Division of Reproductive Endocrinology and Infertility and Vice Chairman of the Department of Obstetrics, Gynecology and Reproductive Science at the Icahn School of Medicine at Mount Sinai, and is Managing Partner at Reproductive Medicine Associates of New York…”
READ MORE
SEMA4 PRESS RELEASE | 09.26.17

Sema4 Appoints Health IT Industry Leader Jamie Coffin as President and Chief Operating Officer

“Sema4 today announced the appointment of Jamie Coffin, Ph.D., as President and Chief Operating Officer. Dr. Coffin has been a leader for more than 20 years within the health information technology (IT) sector, with a background including transforming Dell into the top health IT business in the world and leading the team that grew IBM’s healthcare and life sciences division to a market leader…”
READ MORE
SEMA4 PRESS RELEASE | 09.25.17

Sema4 Partners with PWNHealth to Enable Genetic Testing for Consumers Nationwide

“Sema4 and PWNHealth, whose physicians and genetic counselors provide medical oversight and counseling for testing, today announced a new partnership to enable genetic testing for consumers on a nationwide basis. PWNHealth will provide physician oversight for Sema4’s newest product…”
READ MORE
HARTFORD COURANT | 09.17.17

Interview with Eric Schadt About Connecticut’s Bioscience Industry and Sema4’s Investment in Connecticut

“Sema4, a health information company spun out from the Icahn School of Medicine at Mount Sinai in New York City, operates in Stamford and Branford. Founder Eric Schadt called Branford a “little biotech hub” and Stamford has developed extensive network bandwidth…”
READ MORE
WALL STREET JOURNAL | 09.12.17

Genetic Screening of Parents and Embryos Spreads as Costs Fall

“The revolution in genomics is not only changing the way people who carry genetic diseases have children. It is starting to make its way into everyone else’s family planning, too. As the ability to analyze big data grows, doctors can now tell with much more accuracy and ease whether two people are carriers of a huge catalog of genetic diseases before the couple starts trying to have a child. One test, from Sema4, part of the Mount Sinai Health System in New York, identifies 281 separate illnesses…”
READ MORE
SEMA4 PRESS RELEASE | 09.11.17

Scientists at Sema4 and Mount Sinai Construct First Predictive Model of Inflammatory Bowel Disease

“Scientists at the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions today published results of an in-depth, multi-’omics approach to characterizing the immune component of inflammatory bowel disease (IBD). These results provide new insights into the biologic networks involved in IBD with potential to identify new targets and eventually novel interventions for the treatment of patients living with IBD…”
READ MORE
HUMAN PROOF OF CONCEPT | 08.31.17

Giving It His Best Schadt

“Eric Schadt may enjoy the simple things in life — high velocity, a good polo shirt — but he is the first to admit that life is not simple. Living things are such complex systems, in fact, that our best chance to promote wellness is to understand them as vast information networks…”
READ MORE